IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells
about
The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityLearning about the Importance of Mutation Prevention from Curable Cancers and Benign TumorsInterleukin-17 Could Promote Breast Cancer Progression at Several Stages of the DiseaseIL-17 family: cytokines, receptors and signalingTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeLymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis.Phytochemicals Approach for Developing Cancer Immunotherapeutics.Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cellsRORα suppresses breast tumor invasion by inducing SEMA3F expressionTargeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis.Acute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden.Tumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resectionIL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells.IL-25 blockade inhibits metastasis in breast cancerInterleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation.Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris.Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway.A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation.Pathways Involved in Formation of Mammary Organoid Architecture Have Keys to Understanding Drug Resistance and to Discovery of Druggable Targets.IL-25 in allergic inflammation.Prospective dual role of mesenchymal stem cells in breast tumor microenvironment.Regulation of Interleukin-17 Production.TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model.The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.
P2860
Q26750673-8B9D1AA7-1E21-45A5-8402-BA3E1C1AEA1FQ26766238-FF0C7E81-B13B-46FF-A501-1406695FCE4AQ26771264-A7186BE4-3934-4D7D-8C25-7D37A967635CQ26860251-25235939-0AEB-422A-9E89-96CF0D8F216CQ28066522-EEDE674D-5A7E-4E15-A6C8-3514993C7222Q33776130-A7843B02-E9D0-4A0B-85A0-C8FB60DCCA8DQ33809573-846C9E4E-67BB-4E54-845A-5537985928D1Q33930062-475710C7-2F28-4F7F-B577-1978A332A54AQ34255775-B6460DDB-D947-4F9D-8AFF-72763457FC9DQ35161476-0A5FF67C-4862-4458-BF69-D474995D0A0BQ36201380-6806052C-26DB-4E7E-AE20-7ACBCE69D555Q36288515-69DE6530-F9F8-41C6-BBFB-D7CF57617ADAQ36557288-8800A787-7953-4385-BA4B-1B568653744DQ36815168-BBBE5F06-918C-4B15-BBE1-EE60DD625108Q36890647-382245C4-DDBF-4E63-9BF7-7DF649CADA6BQ36998164-5E7D0D06-EB0B-4B94-A2E6-5419CA20C38FQ37619759-688CA269-1834-47A6-B75B-96327AE81566Q37666893-ED22A0EB-CE72-400A-B57F-D7E6D86EBC7BQ38885474-F8BCE4DA-12BF-4DBF-B3AE-441BD870CD33Q39084902-C01FAF25-3EBC-4C45-A9DC-DE3E76487908Q39126208-98F27C47-C663-442F-A665-270B170A0168Q39162894-1E4FFD78-74A1-41DE-8C28-0415E6B02951Q39247023-B68AF403-3DD6-41C8-B694-61D936C4859BQ39402916-3525302F-3A84-4341-9108-324FA4C5A27FQ39446303-2D81B2CC-05F6-464C-BD76-0B5675CB0B28Q40508654-D2093063-8C00-4ABA-BDBC-D6C48F9AB44EQ46036329-13ADA3D8-A395-4215-B42C-F916659C91F3Q47792012-363A6585-B9AB-49F7-9C6C-047EABE9139DQ49678810-4221DED5-60B4-4E63-A419-5669AA894956Q51092841-5C972999-13BF-4B01-B2C6-D4F1CAFB654CQ51770984-6C6E68F4-51D8-4420-A453-D8A397058345
P2860
IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@ast
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@en
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@nl
type
label
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@ast
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@en
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@nl
prefLabel
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@ast
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@en
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@nl
P2093
P2860
P3181
P1476
IL-25 causes apoptosis of IL-2 ...... toxicity to nonmalignant cells
@en
P2093
Irene Kuhn
Longen Zhou
Mina J Bissell
Wen-Hwa Lee
P2860
P304
P3181
P356
10.1126/SCITRANSLMED.3001374
P407
P577
2011-04-13T00:00:00Z